Core Laboratories Q3 2026 earnings

CLB · 2026-10-28 16:22 AMC ET · 8-K on SEC · 10-Q on SEC

Revenue up 6% sequentially to $132.1M; operating income up 32% sequentially to $12.1M; adjusted EPS up 46% sequentially to $0.16.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$132.1M-2%+6%Ex. 99.1, income statement
EPS (GAAP)$0.12-60%—%Ex. 99.1, income statement
EPS (adjusted)$0.16-27%+46%Ex. 99.1, income statement
Net income$5.46M-62%NMEx. 99.1, income statement
Adj. EBITDA$12.6M-24%+35%Ex. 99.1, income statement
Adj. EBITDA margin10%-2 pp+2 ppEx. 99.1, income statement

Revenue breakdown

SegmentActualYoYShare of revenueNote
Reservoir Description$84.3M-4%64%Operating income $7.7M (GAAP), $8.1M (ex-items), margins 10%
Production Enhancement$47.8M3%36%Operating income $4.3M (GAAP), $4.4M (ex-items), margins 9%

Margins and costs

  • Gross margin 9.4% (prior 7.3%, change +2.1 pp)
  • Operating expenses $120.0M (+4% YoY)
  • One-offs in the quarter Inventory and asset write-downs, lease termination, other exit costs and severance: $0.6M; Foreign exchange losses: $0.5M
  • Effective tax rate 41.0% (prior-year 21%, year-to-date 28.0%)
  • Non-GAAP bridge Adds back stock compensation, inventory/asset write-downs, lease termination, exit costs, severance, foreign exchange losses, and insurance recovery; excludes foreign exchange gains/losses.

KPIs

MetricActualPrior quarterPrior yearChange
Free cash flow$1.7M$3.1M$2.4M-45%
ROIC5.9%8.3%N/A-2.4 pp
Leverage ratio<1.501.30N/A+0.2 pp

Guidance

MetricGuidePrior guideChange
Revenue$128.5M - $134.5M$128.5M - $135.5MFlat to -1 pp
EPS$0.12 - $0.20$0.12 - $0.20Flat

What drove it

  • Revenue story Reservoir Description revenue up 7% sequentially; Production Enhancement revenue up 4% sequentially; total revenue up 6% sequentially.
  • EPS story Adjusted EPS up 46% sequentially driven by higher operating income and lower share count.
  • One-off check Inventory and asset write-downs, lease termination, other exit costs and severance: $0.6M (Q3 2026); Insurance recovery on property, plant and equipment: $0 (Q3 2026).

The good

  • Reservoir Description operating income up 109% sequentially to $7.7M
  • Adjusted operating income up 35% sequentially to $12.6M
  • Adjusted EPS up 46% sequentially to $0.16

The bad

  • Adjusted EPS down 27% year-over-year
  • Adjusted operating income down 24% year-over-year
  • Free cash flow down 45% sequentially to $1.7M

The ugly

  • none

Open questions

  • What specific factors caused the 652.7% increase in income tax expense year-over-year?
  • Why did the effective tax rate jump to 41.0% in Q3 2026 from 8.0% in Q2 2026?
  • Why did ROIC decline to 5.9% in Q3 2026 from 8.3% in Q2 2026?
Full release

Earnings: CLB — filed 2026-10-28

Core Laboratories Inc. (CLB) · Form 8-K, Item 2.02 · Filed · SEC filing

CORE LAB REPORTS THIRD QUARTER 2026 RESULTS:

• REVENUE OF $132.1 MILLION, UP 6% SEQUENTIALLY AND DOWN 2% YEAR-OVER-YEAR

• OPERATING INCOME OF $12.1 MILLION; EX-ITEMS, $12.6 MILLION, UP 35% SEQUENTIALLY AND DOWN 24% YEAR-OVER-YEAR

• GAAP EARNINGS PER SHARE OF $0.12; EPS EX-ITEMS OF $0.16, UP 46% SEQUENTIALLY AND DOWN 27% YEAR-OVER-YEAR

• FREE CASH FLOW OF $1.7 MILLION

• COMPANY REPURCHASED 87,873 SHARES OF COMMON STOCK, FOR $1.1 MILLION AGGREGATE PURCHASE PRICE

• COMPANY ANNOUNCES Q4 2026 QUARTERLY DIVIDEND

HOUSTON (October 28, 2026)—Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported third quarter 2026 revenue of $132,100,000. Core’s operating income was $12,100,000, with earnings per diluted share (“EPS”) of $0.12, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $12,600,000, yielding operating margins of 10% with sequential incremental margins of 43%, and EPS, ex-items, of $0.16. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

Core’s CEO, Larry Bruno, stated, “Our third quarter results delivered sequential revenue growth across both of our operating segments. International revenue was up in Europe-Africa, Asia-Pacific, Latin America, and the Middle East. There was a gradual improvement in activity in the Middle East, particularly late in the quarter. Improving demand across these international regions drove Reservoir Description revenue higher during the quarter, just above the top end of our guidance range. Production Enhancement’s revenue growth was led by strong U.S. product sales, which benefited from modestly improved U.S. land completion activity and increased adoption of our proprietary completion technologies. International product sales also strengthened sequentially.

Looking at the mid to long term, we see our key international regions positioned for growth, including long-cycle offshore exploration and appraisal projects. Face-to-face meetings with clients throughout Asia-Pacific during the third quarter reinforced our view that the region is entering a period of sustained activity growth, with projects advancing across both conventional and unconventional plays. Core Lab's established global network has the Company well-positioned to support these programs. Although geopolitical conflicts in the Middle East and Russia-Ukraine still affect portions of our business, we are encouraged by improving demand and project momentum across our global client base.”

Reservoir Description

Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the United States. Revenue for Reservoir Description in the third quarter of 2026 was $84,300,000, up 7% sequentially and down 4% year-over-year. Operating income on a GAAP basis was $7,700,000. Operating income, ex-items, was $8,100,000, yielding operating margins of 10% and strong sequential incremental margins of 78%.

Sequential revenue growth was driven by increased international demand for the Company's laboratory services, led by project work in Europe-Africa, Asia-Pacific, Latin America and the Middle East. Demand for assay services in the Middle East showed modest improvement late in the quarter but remained below pre-conflict levels. Ongoing geopolitical instability and associated sanctions in the Middle East and Russia-Ukraine continued to weigh on demand for these services.

During the third quarter of 2026, following the successful completion of an initial reservoir characterization study, a leading national oil company in the Middle East awarded Core Lab an expanded analytical program to evaluate its unconventional reservoirs. The initial study combined Core’s proprietary technologies and integrated laboratory workflows to determine reservoir quality and fluid saturations. The expanded program will utilize Core Lab’s PRISM™ workflow, together with the Company’s proprietary High Frequency NMR, NANO-k™ 100 Nano Permeametry, and Shale Matrix Permeameter (“SMP-200™”) technologies. By integrating these laboratory measurements with other petrophysical and geological data, Core Lab is characterizing rock properties and fluid saturations, while also differentiating movable and immovable hydrocarbons. These datasets will assist the operator in evaluating hydrocarbon production potential and support development planning.

Also, during the third quarter of 2026, Omega Oil and Gas engaged Core’s team to evaluate more than 360 feet of conventional core and sidewall cores from two appraisal wells in Queensland’s Taroom Trough in the Bowen Basin. High-quality whole core recovered from multiple hydrocarbon-bearing stratigraphic horizons are undergoing a comprehensive reservoir characterization program at Core Lab’s Advanced Technology Center in Perth, Australia. Upon arrival at the laboratory, the cores were scanned using the Company’s proprietary, non-invasive Dual Energy Computed Tomography technology. This technology provides early lithologic and petrophysical data to support the operator’s initial assessment of potential pay intervals ahead of traditional physical laboratory measurements. The ongoing analytical program will combine these datasets to characterize reservoir quality and calibrate well logs, supporting Omega’s appraisal of the resource. Core Lab is pleased to be assisting Omega Oil and Gas and its technical experts in the evaluation of this emerging play.

Production Enhancement... (truncated)d 3% year-over-year. Operating income for the third quarter on a GAAP basis was $4,300,000. Operating income, ex-items, was $4,400,000, yielding operating margins of 9%.

Sequential revenue growth was led by product sales, which rose 14%, with increases in both U.S. land and international markets. In the U.S., sales benefited from increased demand for the Company's completion products and growing adoption of its proprietary completion technologies. International product sales grew across Europe, Asia-Pacific and the Middle East. These gains were partially offset by the timing of diagnostic service activity in the Gulf of America, as several large projects originally scheduled for the third quarter were delayed, impacting both revenue and operating margins.

During the third quarter of 2026, a North American oilfield service company engaged Core Lab to enhance the efficiency and precision of its perforating operations. Core supplied its proprietary AERO FLEX™, AERO POINT™, and AERO SET™ technologies, together with field implementation support. The integrated AERO™ platform enabled the client to configure perforating assemblies for varying well requirements, simplifying assembly and redress procedures, and precisely orienting perforating charges within the wellbore. These engineered capabilities reduce preparation time and improve placement accuracy while supporting more consistent execution across multiple completion programs. Following successful field deployment, the client is expanding adoption of the AERO™ product family throughout its North American operations.

Also during the third quarter, a Brazilian independent oil and gas operator focused on revitalizing mature onshore fields engaged Core Lab to support a waterflood optimization project. To improve sweep efficiency, the operator implemented a polymer treatment followed by a conventional waterflood traced with Core’s proprietary SpectraFlood™ technology. Analysis of produced water samples collected across the field showed delayed tracer breakthrough, indicating the polymer treatment was effective in slowing flood-front movement as intended. Given these results, the operator is expanding its use of Core Lab’s flood diagnostic technology throughout its portfolio of more than 50 conventional assets, enhancing revenue opportunities for the Company in South America.

Liquidity, Free Cash Flow, Share Repurchases, and Dividend

Core continues to focus on maximizing free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures. For the third quarter of 2026, cash from operations was $5,000,000, and capital expenditures associated with operations were $3,300,000, yielding FCF of $1,700,000. Certain raw materials used in the manufacturing of perforating systems have increased the cost of carrying inventory. Additionally, activity for both operating segments increased as we exited the third quarter of 2026, resulting in a higher level of accounts receivable at the end of the quarter. These two factors resulted in an increase of working capital as of September 30, 2026.

As previously disclosed, a fire in February 2024 damaged a building at Core Lab's Advanced Technology Center in Aberdeen, Scotland, and the related losses are covered by the Company's property and casualty insurance. Insurance proceeds, along with capital expenditures to replace equipment and restore the building, are reported separately within investing activities in the cash flow statement and are excluded from the calculation of FCF. These capital expenditures were approximately $500,000 in the third quarter of 2026.

In the third quarter of 2026, Core Lab repurchased 87,873 shares at an aggregate purchase price of approximately $1,100,000.

As of September 30, 2026, Core’s net debt (defined as long-term debt less cash and cash equivalents) was $93,400,000, a reduction of $200,000. Also during the third quarter of 2026, the Company’s leverage ratio (calculated as total net debt divided by trailing twelve months adjusted EBITDA) was under 1.50. The Company remains focused on executing its strategic initiatives and continues to evaluate the allocation of capital between debt reduction and other uses of free cash that return value to shareholders.

On July 29, 2026, Core’s Board of Directors ("Board") announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on August 31, 2026, to shareholders of record on August 10, 2026.

On October 28, 2026, the Board approved a cash dividend of $0.01 per share of common stock, payable on November 30, 2026, to shareholders of record on November 9, 2026.

Return on Invested Capital

The Board and the Company's executive management remain focused on strategies that maximize return on invested capital ("ROIC") and FCF, measures the Company believes are closely correlated with total shareholder return. Core's asset-light business model and disciplined approach to capital allocation are intended to promote capital efficiency and deliver superior, more predictable ROIC over the long term.

The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield services companies listed as Core's Comp Group by Bloomberg, as the Company continues to believe superior ROIC will result in higher total shareholder return. Using Bloomberg’s formula, Core Lab’s ROIC for the third quarter of 2026 was 5.9%.

Industry and Core Lab Outlook and Guidance... (truncated) the timing of upstream client activity. These geopolitical events also impacted upstream operations and slowed the pace of client projects.

Higher energy prices and constrained availability of certain petroleum products have weighed on crude oil demand in the near term. Looking ahead, the IEA, EIA and OPEC all anticipate strong global crude oil demand growth in 2027 as supply disruptions ease and trade flows normalize. Short-cycle U.S. onshore activity is more sensitive to crude oil price volatility, while large-scale international projects are expected to be more resilient and proceed as planned, unless directly impacted by regional conflicts. Overall, the Company believes the historic disruption to the global supply of oil and gas caused by the Middle East conflict will support improved activity in 2027, and a long-term growth cycle for oilfield services. Natural production declines from existing fields, the need to rebuild depleted global inventories, and clients’ increasing focus on reserve replacement, underscores the importance of investment in new sources of production and in maximizing recovery from existing fields. Core Lab’s reservoir characterization and production optimization technologies support operators in evaluating new resources, reducing development risk, and improving recovery from producing reservoirs.

For the fourth quarter of 2026, Core Lab expects revenue to remain relatively flat sequentially, reflecting continued disruptions in the Middle East. Early in the fourth quarter, attacks affected client operations in the region and have already resulted in some project delays.

In the U.S., Core expects the customary year-end seasonal moderation in land completion activity, partially offset by sequential improvement in diagnostic services. A sequential increase in Production Enhancement service activity is expected to drive growth quarter over quarter.

Although recovery in certain Middle East countries remains difficult to predict, Core Lab’s international laboratory network, proprietary technologies, and specialized expertise position the Company to capitalize on emerging opportunities across global markets.

Reservoir Description’s fourth quarter 2026 revenue is projected to range from $81,000,000 to $85,000,000, with operating income of $5,100,000 to $8,300,000. Production Enhancement’s fourth quarter revenue is estimated to range from $47,500,000 to $49,500,000, with operating income of $5,500,000 to $6,700,000. Core’s fourth quarter 2026 revenue is projected to range from $128,500,000 to $134,500,000, with operating income of $10,700,000 to $15,100,000, yielding operating margins of approximately 10%. EPS for the fourth quarter of 2026 is expected to be $0.12 to $0.20.

The Company’s guidance is based on projections for underlying operations and excludes gains and losses in foreign exchange, and assumes an effective tax rate of 25%.

Earnings Call Scheduled

The Company has scheduled a conference call to discuss Core's third quarter 2026 earnings announcement. The call will begin at 7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, October 29, 2026. To access the listen-only webcast, visit www.corelab.com/investors 15 minutes before the start of the call. For those not available to listen to the live webcast, a replay and transcript will be available on the Company’s website shortly after the call. Analysts may contact investor.relations@corelab.com for conference call dial-in information.

Financial statements

Income Statement

Three Months Ended — (Unaudited) (in thousands)

Three Months Ended – September 30, 2026Three Months Ended – June 30, 2026Three Months Ended – September 30, 2025% Variance – vs. Q2-26% Variance – vs. Q3-25
REVENUE132,077124,609134,5216.0%-1.8%
OPERATING EXPENSES:Costs of services and product sales105,092101,371104,9013.7%0.2%
OPERATING EXPENSES:General and administrative expense11,26810,95310,6882.9%5.4%
OPERATING EXPENSES:Depreciation and amortization3,7243,8253,594-2.6%3.6%
OPERATING EXPENSES:Other (income) expense, net-72-691-5,590NMNM
OPERATING EXPENSES:Total operating expenses120,012115,458113,5933.9%5.7%
OPERATING EXPENSES:OPERATING INCOME12,0659,15120,92831.8%-42.3%
OPERATING EXPENSES:Interest expense2,7862,8462,650-2.1%5.1%
OPERATING EXPENSES:Income before income taxes9,2796,30518,27847.2%-49.2%
OPERATING EXPENSES:Income tax expense3,8165073,754652.7%1.7%
OPERATING EXPENSES:Net income5,4635,79814,524NM-62.4%
OPERATING EXPENSES:Net income (loss) attributable to non-controlling interest19-158285NMNM
OPERATING EXPENSES:Net income attributable to Core Laboratories Inc.5,4445,95614,239-8.6%-61.8%
OPERATING EXPENSES:Diluted earnings per share0.120.120.31—%-61.3%
OPERATING EXPENSES:Diluted earnings per share attributable to Core Laboratories Inc.0.120.130.3-7.7%-60.0%
OPERATING EXPENSES:Diluted weighted average common shares outstanding46,71146,87847,078-0.4%-0.8%
OPERATING EXPENSES:Effective tax rate41.0%8.0%21NMNM
Revenue:Reservoir Description84,31878,74788,2247.1%-4.4%
Revenue:Production Enhancement47,75945,86246,2974.1%3.2%
Revenue:Consolidated132,077124,609134,5216.0%-1.8%
Operating income:Reservoir Description7,7033,67816,574109.4%-53.5%
Operating income:Production Enhancement4,3275,2284,379-17.2%-1.2%
Operating income:Corporate and Other35245-25NMNM
Operating income:Consolidated12,0659,15120,92831.8%-42.3%

Income Statement

Nine Months Ended September 30, — (Unaudited) (in thousands)

Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025% Variance
REVENUE378,483388,265-2.5%
OPERATING EXPENSES:Costs of services and product sales308,536308,0710.2%
OPERATING EXPENSES:General and administrative expense36,93934,7996.1%
OPERATING EXPENSES:Depreciation and amortization11,31310,9813.0%
OPERATING EXPENSES:Other (income) expense, net-1,408-6,222NM
OPERATING EXPENSES:Total operating expenses355,380347,6292.2%
OPERATING EXPENSES:OPERATING INCOME23,10340,636-43.1%
OPERATING EXPENSES:Interest expense8,5237,9637.0%
OPERATING EXPENSES:Income before income taxes14,58032,673-55.4%
OPERATING EXPENSES:Income tax expense4,0727,411-45.1%
OPERATING EXPENSES:Net income10,50825,262-58.4%
OPERATING EXPENSES:Net income (loss) attributable to non-controlling interest-103541NM
OPERATING EXPENSES:Net income attributable to Core Laboratories Inc.10,61124,721-57.1%
OPERATING EXPENSES:Diluted earnings per share0.220.53-58.5%
OPERATING EXPENSES:Diluted earnings per share attributable to Core Laboratories Inc.0.230.52-55.8%
OPERATING EXPENSES:Diluted weighted average common shares outstanding46,88347,381-1.1%
OPERATING EXPENSES:Effective tax rate28.0%23.0%NM
Revenue:Reservoir Description244,996255,401-4.1%
Revenue:Production Enhancement133,487132,8640.5%
Revenue:Total378,483388,265-2.5%
Operating income:Reservoir Description12,52731,116-59.7%
Operating income:Production Enhancement10,3599,03014.7%
Operating income:Corporate and Other217490NM
Operating income:Total23,10340,636-43.1%

Income Statement

(Unaudited) (in thousands)

Operating Income – Three Months Ended – September 30, 2026Operating Income – Three Months Ended – June 30, 2026Operating Income – Three Months Ended – September 30, 2025
GAAP reported12,0659,15120,928
Inventory and asset write-downs, lease termination, other exit costs and severance (2)601
Insurance recovery on property, plant and equipment (3)-5,252
Foreign exchange losses (gains)548219354
Excluding specific items12,6139,37016,631

Income Statement

(Unaudited)

Diluted Earnings Per Share Attributable to Core Laboratories Inc. – Three Months Ended – September 30, 2026Diluted Earnings Per Share Attributable to Core Laboratories Inc. – Three Months Ended – June 30, 2026Diluted Earnings Per Share Attributable to Core Laboratories Inc. – Three Months Ended – September 30, 2025Diluted Earnings Per Share Attributable to Core Laboratories Inc. – Nine Months Ended – September 30, 2026
GAAP reported0.120.130.30.23
Stock compensation (1)0.06
Inventory and asset write-downs, lease termination, other exit costs and severance (2)0.010.01
Insurance recovery on property, plant and equipment (3)-0.08
Foreign exchange losses (gains)0.010.010.01
Effect of higher (lower) tax rate (4)0.03-0.02-0.020.01
Excluding specific items0.160.110.220.32

Income Statement

(Unaudited) (in thousands)

Operating Income – Three Months Ended September 30, 2026 – Reservoir DescriptionOperating Income – Three Months Ended September 30, 2026 – Production EnhancementOperating Income – Three Months Ended September 30, 2026 – Corporate and Other
GAAP reported7,7034,32735
Foreign exchange losses (gains)3936986
Excluding specific items8,0964,396121

Balance Sheet

(Unaudited) (in thousands)

September 30, 2026June 30, 2026December 31, 2025% Variance – vs. Q2-26% Variance – vs. Q4-25
Cash and cash equivalents21,37622,73522,702-6.0%-5.8%
Accounts receivable, net115,573108,817113,5286.2%1.8%
Inventories60,69957,96154,4964.7%11.4%
Other current assets27,40724,84723,93910.3%14.5%
Total current assets225,055214,360214,6655.0%4.8%
Property, plant and equipment, net100,840100,39099,4470.4%1.4%
Right of use assets51,14552,87054,346-3.3%-5.9%
Intangibles, goodwill and other long-term assets, net216,478219,158215,552-1.2%0.4%
Total assets593,518586,778584,0101.1%1.6%
LIABILITIES AND EQUITY:Accounts payable40,01240,16337,275-0.4%7.3%
LIABILITIES AND EQUITY:Short-term operating lease liabilities11,71811,94011,456-1.9%2.3%
LIABILITIES AND EQUITY:Other current liabilities51,00248,94757,2844.2%-11.0%
LIABILITIES AND EQUITY:Total current liabilities102,732101,050106,0151.7%-3.1%
LIABILITIES AND EQUITY:Long-term debt, net112,447113,861110,255-1.2%2.0%
LIABILITIES AND EQUITY:Long-term operating lease liabilities37,80639,31442,309-3.8%-10.6%
LIABILITIES AND EQUITY:Other long-term liabilities56,44353,78453,2234.9%6.1%
LIABILITIES AND EQUITY:Total equity284,090278,769272,2081.9%4.4%
LIABILITIES AND EQUITY:Total liabilities and equity593,518586,778584,0101.1%1.6%

Cash Flow

Nine Months Ended September 30, — (Unaudited) (in thousands)

Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
CASH FLOWS FROM OPERATING ACTIVITIES:Net income10,50825,262
Adjustments to reconcile net income to net cash provided by operating activities:Stock-based compensation7,2186,023
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization11,31310,981
Adjustments to reconcile net income to net cash provided by operating activities:Changes in value of life insurance policies-1,251-1,851
Adjustments to reconcile net income to net cash provided by operating activities:Deferred income taxes1,232-4,573
Adjustments to reconcile net income to net cash provided by operating activities:Accounts receivable-2,179-615
Adjustments to reconcile net income to net cash provided by operating activities:Inventories-6,822-1,268
Adjustments to reconcile net income to net cash provided by operating activities:Accounts payable2,6741,284
Adjustments to reconcile net income to net cash provided by operating activities:Accrued expenses-3,598-3,370
Adjustments to reconcile net income to net cash provided by operating activities:Other adjustments to net income-2,352-2,788
Adjustments to reconcile net income to net cash provided by operating activities:Net cash provided by operating activities16,74329,085
CASH FLOWS FROM INVESTING ACTIVITIES:Capital expenditures - operations-11,381-8,265
CASH FLOWS FROM INVESTING ACTIVITIES:Capital expenditures - rebuilding of Aberdeen facility-2,990-2,672
CASH FLOWS FROM INVESTING ACTIVITIES:Net proceeds from insurance recovery1399,951
CASH FLOWS FROM INVESTING ACTIVITIES:Acquisitions, net of cash acquired-617
CASH FLOWS FROM INVESTING ACTIVITIES:Proceeds from sale of assets3,1442,348
CASH FLOWS FROM INVESTING ACTIVITIES:Net proceeds on life insurance policies557778
CASH FLOWS FROM INVESTING ACTIVITIES:Other investing activities18-2
CASH FLOWS FROM INVESTING ACTIVITIES:Net cash provided by (used in) investing activities-10,5131,521
CASH FLOWS FROM FINANCING ACTIVITIES:Repayment of long-term debt-93,250-47,000
CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from long-term debt95,00036,000
CASH FLOWS FROM FINANCING ACTIVITIES:Debt issuance costs-1,706
CASH FLOWS FROM FINANCING ACTIVITIES:Dividends paid-1,379-1,403
CASH FLOWS FROM FINANCING ACTIVITIES:Repurchase of common stock-7,740-9,770
CASH FLOWS FROM FINANCING ACTIVITIES:Other financing activities-187-255
CASH FLOWS FROM FINANCING ACTIVITIES:Net cash used in financing activities-7,556-24,134
CASH FLOWS FROM FINANCING ACTIVITIES:NET CHANGE IN CASH AND CASH EQUIVALENTS-1,3266,472

Cash Flow

Three Months Ended — (Unaudited) (in thousands)

Three Months Ended – September 30, 2026Nine Months Ended – September 30, 2026
Net cash provided by operating activities4,96916,743
Capital expenditures - operations-3,246-11,381
Free cash flow1,7235,362

Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements Core Lab makes, includes forward-looking statements regarding the Company’s future revenue, profitability, business strategies and developments, demand for the Company’s products and services and for products and services of the oil and gas industry generally, made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the impact of tariffs, supply chain disruptions, trade policies and sanctions, international civil unrest or geopolitical tensions, including the continuing armed conflict between Russia and Ukraine, escalation of military conflict between the United States, Israel and Iran, and political conditions in South America, most recently in Venezuela, severe weather events, the severity and duration of public health crises, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.

The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.... (truncated)

For more information, contact:

Gwen Gresham - SVP Corporate Development and Investor Relations

Phone: +1 713 328 6210

E-mail: investor.relations@corelab.com

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.